Literature DB >> 35761015

Renal sarcoidosis.

Marta Calatroni1,2, Gabriella Moroni3,4, Francesco Reggiani3,4, Claudio Ponticelli5.   

Abstract

Sarcoidosis is a systemic inflammatory disease of unknown etiology. The pathogenesis rests on an aberrant T cell response to unidentified antigens in individuals predisposed by genetic and environmental factors. Increased expression of polarized macrophages and disequilibrium between effector and regulator T cells contribute to the formation of noncaseating granulomas, that are frequently found in affected organs. The main kidney abnormalities in sarcoidosis are granulomatous interstitial nephritis (GIN) and hypercalcemia-related disorders. The clinical diagnosis is difficult. The outcome is variable, ranging from spontaneous remission to end-stage kidney disease (ESKD). Early diagnosis and prompt treatment with corticosteroids can improve the prognosis. Hypercalcemia may be responsible for acute kidney injury (AKI) caused by vasoconstriction of afferent arterioles. Complications of persistent hypercalcemia include nephrocalcinosis and renal stones. In patients with ESKD, dialysis and transplantation can offer results comparable to those observed in patients with other causes of kidney failure. Based on a review of the literature, we present an overview of the etiopathogenesis, the renal manifestations of sarcoidosis and their complications, management and prognosis.
© 2022. The Author(s) under exclusive licence to Italian Society of Nephrology.

Entities:  

Keywords:  Acute kidney injury; End-stage kidney disease; Granulomatous interstitial nephritis; Hypercalcemia; Noncaseating granulomas; Renal sarcoidosis

Year:  2022        PMID: 35761015     DOI: 10.1007/s40620-022-01369-y

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   4.393


  134 in total

Review 1.  Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors.

Authors:  Elizabeth V Arkema; Yvette C Cozier
Journal:  Curr Opin Pulm Med       Date:  2020-09       Impact factor: 3.155

Review 2.  How the Frequency and Phenotype of Sarcoidosis is Driven by Environmental Determinants.

Authors:  Manuel Ramos-Casals; Belchin Kostov; Pilar Brito-Zerón; Antoni Sisó-Almirall; Robert P Baughman
Journal:  Lung       Date:  2019-06-12       Impact factor: 2.584

3.  Sarcoidosis and increased risk of comorbidities and mortality in sweden.

Authors:  Johanna Larsson; Pål Graff; Ing-Liss Bryngelsson; Per Vihlborg
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-06-30       Impact factor: 0.670

4.  The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study.

Authors:  A Pietinalho; Y Hiraga; Y Hosoda; A B Löfroos; M Yamaguchi; O Selroos
Journal:  Sarcoidosis       Date:  1995-03

5.  Drug-induced sarcoidosis-like reactions.

Authors:  Jelle Miedema; Hilario Nunes
Journal:  Curr Opin Pulm Med       Date:  2021-06-28       Impact factor: 3.155

Review 6.  Renal sarcoidosis: approach to diagnosis and management.

Authors:  Raoul Bergner; Christian Löffler
Journal:  Curr Opin Pulm Med       Date:  2018-09       Impact factor: 3.155

Review 7.  Is there any association between Sarcoidosis and infectious agents?: a systematic review and meta-analysis.

Authors:  Tiago Esteves; Gloria Aparicio; Vicente Garcia-Patos
Journal:  BMC Pulm Med       Date:  2016-11-28       Impact factor: 3.317

8.  Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study.

Authors:  Hee-Young Yoon; Hyeong Min Kim; Ye-Jee Kim; Jin Woo Song
Journal:  Respir Res       Date:  2018-08-28

Review 9.  Sarcoidosis Epidemiology: Race Matters.

Authors:  Kerry Maryse Hena
Journal:  Front Immunol       Date:  2020-09-15       Impact factor: 7.561

10.  Sarcoidosis: A nationwide registry-based study of incidence, prevalence and diagnostic work-up.

Authors:  Melina Gade Sikjær; Ole Hilberg; Rikke Ibsen; Anders Løkke
Journal:  Respir Med       Date:  2021-07-30       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.